The Oncosearch | Oncotarget

Retraction: Matrine alleviates lipopolysaccharide-induced intestinal inflammation and oxidative stress via CCR7 signal Retraction

Guojun Wu, Wenhong Zhou, Junfeng Zhao, Xiaohua Pan, Yongjie Sun, Hao Xu, Peng Shi, Chong Geng, Ling Gao, Xingsong Tian

Published Nov 3, 2021 · Vol. 14, No. 1 · pp. 943-943

Anaplastic lymphoma kinase rearrangement prevalence in patients with advanced non-small cell lung cancer in the United States: retrospective real world data Research Paper

Timothy Craig Allen, Yan Xiao, Baiyu Yang, Denise Croix, Anup Abraham, Stella Redpath, Julia Engstrom-Melynk, Roma Shah, Jaya Madala, Eric H. Bernicker

Published Oct 29, 2021 · Vol. 12, No. 23 · pp. 2308-2315

Keywords: ALK rearrangement, NSCLC, prevalence

Correction: Metformin and trametinib have synergistic effects on cell viability and tumor growth in NRAS mutant cancer Correction

Igor Vujic, Martina Sanlorenzo, Christian Posch, Rosaura Esteve-Puig, Adam J. Yen, Andrew Kwong, Aaron Tsumura, Ryan Murphy, Klemens Rappersberger, Susana Ortiz-Urda

Published Oct 29, 2021

Correction: NOX4 promotes non-small cell lung cancer cell proliferation and metastasis through positive feedback regulation of PI3K/Akt signaling Correction

Cuixiang Zhang, Tian Lan, Jincai Hou, Juan Li, Rende Fang, Zhicheng Yang, Min Zhang, Jianxun Liu, Bing Liu

Published Oct 28, 2021

Correction: PKM2 promotes metastasis by recruiting myeloid-derived suppressor cells and indicates poor prognosis for hepatocellular carcinoma Correction

Wei-Ren Liu, Meng-Xin Tian, Liu-Xiao Yang, Yu-Li Lin, Lei Jin, Zhen-Bin Ding, Ying-Hao Shen, Yuan-Fei Peng, Dong-Mei Gao, Jian Zhou, Shuang-Jian Qiu, Zhi Dai, Rui He, Jia Fan, Ying-Hong Shi

Published Oct 28, 2021

Correction: Lysosomal sequestration of hydrophobic weak base chemotherapeutics triggers lysosomal biogenesis and lysosome-dependent cancer multidrug resistance Correction

Benny Zhitomirsky, Yehuda G. Assaraf

Published Oct 28, 2021 · Vol. 13, No. 1 · pp. 585-586

Correction: Melanoma cell therapy: Endothelial progenitor cells as shuttle of the MMP12 uPAR-degrading enzyme Correction

Anna Laurenzana, Alessio Biagioni, Silvia D’Alessio, Francesca Bianchini, Anastasia Chillà, Francesca Margheri, Cristina Luciani, Benedetta Mazzanti, Nicola Pimpinelli, Eugenio Torre, Silvio Danese, Lido Calorini, Mario Del Rosso, Gabriella Fibbi

Published Oct 28, 2021

Correction: The receptor for urokinase-plasminogen activator (uPAR) controls plasticity of cancer cell movement in mesenchymal and amoeboid migration style Correction

Francesca Margheri, Cristina Luciani, Maria Letizia Taddei, Elisa Giannoni, Anna Laurenzana, Alessio Biagioni, Anastasia Chillà, Paola Chiarugi, Gabriella Fibbi, Mario Del Rosso

Published Oct 28, 2021

Correction: Cdc6 contributes to cisplatin-resistance by activation of ATR-Chk1 pathway in bladder cancer cells Correction

Sansan Chen, Xinglu Chen, Gui’e Xie, Yue He, Daoyu Yan, Dianpeng Zheng, Shi Li, Xinyang Fu, Yeping Li, Xiang Pang, Zhiming Hu, Hongwei Li, Wanlong Tan, Jinlong Li

Published Oct 26, 2021

Correction: Next-generation multimodality of nutrigenomic cancer therapy: sulforaphane in combination with acetazolamide actively target bronchial carcinoid cancer in disabling the PI3K/Akt/mTOR survival pathway and inducing apoptosis Correction

Reza Bayat Mokhtari, Bessi Qorri, Narges Baluch, Angelo Sparaneo, Federico Pio Fabrizio, Lucia Anna Muscarella, Albina Tyker, Sushil Kumar, Hai-Ling Margaret Cheng, Myron R. Szewczuk, Bikul Das, Herman Yeger

Published Oct 22, 2021 · Vol. 13, No. 1 · pp. 968-969

Correction: Selective killing of gastric cancer cells by a small molecule via targeting TrxR1 and ROS-mediated ER stress activation Correction

Weiqian Chen, Peng Zou, Zhongwei Zhao, Qiaoyou Weng, Xi Chen, Shilong Ying, Qingqing Ye, Zhe Wang, Jiansong Ji, Guang Liang

Published Oct 19, 2021

The “Immunoscore” in rectal cancer: could we search quality beyond quantity of life? Research Perspective

Amos Kirilovsky, Carine El Sissy, Guy Zeitoun, Florence Marliot, Nacilla Haicheur, Christine Lagorce-Pagès, Julien Taieb, Mehdi Karoui, Petra Custers, Edina Dizdarevic, Soledad Iseas, Torben Frøstrup Hansen, Lars Henrik Jensen, Geerard Beets, Jean Pierre Gérard, Mireia Castillo-Martin, Nuno Figueiredo, Angelita Habr-Gama, Rodrigo Perez, Jérôme Galon, Franck Pagès

Published Oct 16, 2021 · Vol. 13, No. 1 · pp. 18-31

Keywords: rectal cancer, immunoscore, watch and wait, prognosis, radiochemotherapy

THBS2 as a prognostic biomarker for patients diagnosed with metastatic pancreatic ductal adenocarcinoma Research Paper

Phyllis A. Gimotty, Jacob E. Till, Shirsa Udgata, Naomi Takenaka, Stephanie S. Yee, Michael J. LaRiviere, Mark H. O’Hara, Kim A. Reiss, Peter O'Dwyer, Bryson W. Katona, Daniel Herman, Erica L. Carpenter, Kenneth S. Zaret

Published Oct 15, 2021 · Vol. 12, No. 22 · pp. 2266-2272

Keywords: pancreatic cancer, metastasis, biomarkers, prognosis, THBS2

Unravelling the underpinnings of hyperprogression and immunotherapy: back to the bench Editorial

Vivek Subbiah, Razelle Kurzrock

Published Oct 15, 2021 · Vol. 13, No. 1 · pp. 13-15

Keywords: hyperprogression, immunotherapy, mouse model, PD-1, checkpoint

Are 50 years enough to prove the brilliant Dilman’s idea? Editorial

Vladimir N. Anisimov

Published Oct 13, 2021 · Vol. 13, No. 1 · pp. 90-91

Keywords: antidiabetic biguanides, metformin, cancer prevention, milestones

Correction: Betulinic acid impairs metastasis and reduces immunosuppressive cells in breast cancer models Correction

An-Qi Zeng, Yan Yu, Yu-Qin Yao, Fang-Fang Yang, Mengya Liao, Lin-Jiang Song, Ya-Li Li, Yang Yu, Yu-Jue Li, Yuan-Le Deng, Shu-Ping Yang, Chen-Juan Zeng, Ping Liu, Yong-Mei Xie, Jin-Liang Yang, Yi-Wen Zhang, Ting-Hong Ye, Yu-Quan Wei

Published Oct 12, 2021 · pp. 2434-2438

Correction: Tumor suppressor RARRES1 links tubulin deglutamylation to mitochondrial metabolism and cell survival Correction

Sara Maimouni, Mi-Hye Lee, You-Me Sung, Michael Hall, Arpita Roy, Chokri Ouaari, Yoo-Seok Hwang, Justin Spivak, Eric Glasgow, Matthew Swift, Jay Patel, Amrita Cheema, Deepak Kumar, Stephen Byers

Published Oct 7, 2021 · Vol. 12, No. 22 · pp. 2305-2306

Comparison of MET gene amplification analysis by next-generation sequencing and fluorescence in situ hybridization Research Paper

Christina Schmitt, Anna-Alice Schulz, Ria Winkelmann, Kevin Smith, Peter J. Wild, Melanie Demes

Published Oct 5, 2021 · Vol. 12, No. 22 · pp. 2273-2282

Keywords: next-generation sequencing (NGS), non-small cell lung cancer (NSCLC), fluorescence in situ hybridization (FISH), MET amplification, routine diagnostics

Emerging approaches of wound healing in experimental models of high-grade oral mucositis induced by anticancer therapy Review

Ana Chor, Maria Adriana Skeff, Christina Takiya, Raquel Gonçalves, Marcos Dias, Marcos Farina, Leonardo R. Andrade, Valeria de Mello Coelho

Published Oct 1, 2021 · Vol. 12, No. 22 · pp. 2283-2299

Keywords: oral mucositis, inflammation, regeneration, polymers, tissue engineering

ATR inhibition reverses the resistance of homologous recombination deficient MGMT^low/MMR^proficient cancer cells to temozolomide Priority Research Paper

Lara H. El Touny, Curtis Hose, John Connelly, Erik Harris, Anne Monks, Angie B. Dull, Deborah F. Wilsker, Melinda G. Hollingshead, Michelle Gottholm-Ahalt, Sergio Y. Alcoser, Michael E. Mullendore, Ralph E. Parchment, James H. Doroshow, Beverly A. Teicher, Annamaria Rapisarda

Published Sep 28, 2021 · Vol. 12, No. 21 · pp. 2114-2130

Keywords: TMZ, MMR, ATR, HR, REV3L

Publication Alerts

European Cancer and Oncology Congress

Post-Publication Promotion

Search Oncotarget

Retraction: Matrine alleviates lipopolysaccharide-induced intestinal inflammation and oxidative stress via CCR7 signal Retraction

Anaplastic lymphoma kinase rearrangement prevalence in patients with advanced non-small cell lung cancer in the United States: retrospective real world data Research Paper

Correction: Metformin and trametinib have synergistic effects on cell viability and tumor growth in NRAS mutant cancer Correction

Correction: NOX4 promotes non-small cell lung cancer cell proliferation and metastasis through positive feedback regulation of PI3K/Akt signaling Correction

Correction: PKM2 promotes metastasis by recruiting myeloid-derived suppressor cells and indicates poor prognosis for hepatocellular carcinoma Correction

Correction: Lysosomal sequestration of hydrophobic weak base chemotherapeutics triggers lysosomal biogenesis and lysosome-dependent cancer multidrug resistance Correction

Correction: Melanoma cell therapy: Endothelial progenitor cells as shuttle of the MMP12 uPAR-degrading enzyme Correction

Correction: The receptor for urokinase-plasminogen activator (uPAR) controls plasticity of cancer cell movement in mesenchymal and amoeboid migration style Correction

Correction: Cdc6 contributes to cisplatin-resistance by activation of ATR-Chk1 pathway in bladder cancer cells Correction

Correction: Next-generation multimodality of nutrigenomic cancer therapy: sulforaphane in combination with acetazolamide actively target bronchial carcinoid cancer in disabling the PI3K/Akt/mTOR survival pathway and inducing apoptosis Correction

Correction: Selective killing of gastric cancer cells by a small molecule via targeting TrxR1 and ROS-mediated ER stress activation Correction

The “Immunoscore” in rectal cancer: could we search quality beyond quantity of life? Research Perspective

THBS2 as a prognostic biomarker for patients diagnosed with metastatic pancreatic ductal adenocarcinoma Research Paper

Unravelling the underpinnings of hyperprogression and immunotherapy: back to the bench Editorial

Are 50 years enough to prove the brilliant Dilman’s idea? Editorial

Correction: Betulinic acid impairs metastasis and reduces immunosuppressive cells in breast cancer models Correction

Correction: Tumor suppressor RARRES1 links tubulin deglutamylation to mitochondrial metabolism and cell survival Correction

Comparison of MET gene amplification analysis by next-generation sequencing and fluorescence in situ hybridization Research Paper

Emerging approaches of wound healing in experimental models of high-grade oral mucositis induced by anticancer therapy Review

ATR inhibition reverses the resistance of homologous recombination deficient MGMT^low/MMR^proficient cancer cells to temozolomide Priority Research Paper

Publication Alerts

European Cancer and Oncology Congress

Oncoscience

Post-Publication Promotion

Search Oncotarget

Retraction: Matrine alleviates lipopolysaccharide-induced intestinal inflammation and oxidative stress via CCR7 signal Retraction

Anaplastic lymphoma kinase rearrangement prevalence in patients with advanced non-small cell lung cancer in the United States: retrospective real world data Research Paper

Correction: Metformin and trametinib have synergistic effects on cell viability and tumor growth in NRAS mutant cancer Correction

Correction: NOX4 promotes non-small cell lung cancer cell proliferation and metastasis through positive feedback regulation of PI3K/Akt signaling Correction

Correction: PKM2 promotes metastasis by recruiting myeloid-derived suppressor cells and indicates poor prognosis for hepatocellular carcinoma Correction

Correction: Lysosomal sequestration of hydrophobic weak base chemotherapeutics triggers lysosomal biogenesis and lysosome-dependent cancer multidrug resistance Correction

Correction: Melanoma cell therapy: Endothelial progenitor cells as shuttle of the MMP12 uPAR-degrading enzyme Correction

Correction: The receptor for urokinase-plasminogen activator (uPAR) controls plasticity of cancer cell movement in mesenchymal and amoeboid migration style Correction

Correction: Cdc6 contributes to cisplatin-resistance by activation of ATR-Chk1 pathway in bladder cancer cells Correction

Correction: Next-generation multimodality of nutrigenomic cancer therapy: sulforaphane in combination with acetazolamide actively target bronchial carcinoid cancer in disabling the PI3K/Akt/mTOR survival pathway and inducing apoptosis Correction

Correction: Selective killing of gastric cancer cells by a small molecule via targeting TrxR1 and ROS-mediated ER stress activation Correction

The “Immunoscore” in rectal cancer: could we search quality beyond quantity of life? Research Perspective

THBS2 as a prognostic biomarker for patients diagnosed with metastatic pancreatic ductal adenocarcinoma Research Paper

Unravelling the underpinnings of hyperprogression and immunotherapy: back to the bench Editorial

Are 50 years enough to prove the brilliant Dilman’s idea? Editorial

Correction: Betulinic acid impairs metastasis and reduces immunosuppressive cells in breast cancer models Correction

Correction: Tumor suppressor RARRES1 links tubulin deglutamylation to mitochondrial metabolism and cell survival Correction

Comparison of MET gene amplification analysis by next-generation sequencing and fluorescence in situ hybridization Research Paper

Emerging approaches of wound healing in experimental models of high-grade oral mucositis induced by anticancer therapy Review

ATR inhibition reverses the resistance of homologous recombination deficient MGMTlow/MMRproficient cancer cells to temozolomide Priority Research Paper

ATR inhibition reverses the resistance of homologous recombination deficient MGMT^low/MMR^proficient cancer cells to temozolomide Priority Research Paper